An assessment of the use of chimpanzees in hepatitis c research past, present and future: 2. Alternative replacement methods

Alternatives to Laboratory Animals

Volumn 38, Issue 6, 2010, Pages 471-494

  Bailey, Jarrod ^a  

^a New England Anti Vivisection Society   (United States)

Author keywords

Chimpanzee; Hepatitis C; Hepatitis C virus; Hepatocellular carcinoma; Pan troglodytes

Indexed keywords

ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REPLACEMENT; CHIMPANZEE; HEPATITIS C; HEPATITIS C VIRUS; LABORATORY; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; UNITED STATES; VIROGENESIS;

HEPATITIS C VIRUS; PAN; PAN TROGLODYTES;

EID: 79551693363     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119291003800602     Document Type: Review

References (321)

1. Gottwein, J.M. & Bukh, J. (2008). Cutting the Gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Advances in Virus Research 71, 51-133.
2. Marcellin, P. (2009). Hepatitis B and hepatitis C in 2009. Liver International 29, Suppl. 1, 1-8.
3. Soriano, V., Madejon, A., Vispo, E., Labarga, P., Garcia-Samaniego, J., Martin-Carbonero, L., Sheldon, J., Bottecchia, M., Tuma, P. & Barreiro, P. (2008). Emerging drugs for hepatitis C. Expert Opinion on Emerging Drugs 13, 1-19. (Pubitemid 351448700)
4. Poynard, T., Bedossa, P. & Opolon, P. (1997). Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349, 825-832. (Pubitemid 27129209)
5. Lauer, G.M. & Walker, B.D. (2001). Hepatitis C virus infection. New England Journal of Medicine 345, 41-52. (Pubitemid 32634271)
6. Walters, K-A. & Katze, M.G. (2009). Using highthroughput genomics to study hepatitis C: What determines the outcome of infection? Antiviral Research 81, 198-208.
7. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, New York 244, 359-362. (Pubitemid 19117877)
8. NEAVS (2010). End Chimpanzee Research: Overview - International Bans. Boston, MA, USA: New England Anti-Vivisection Society (Project R&R). Available at: http://www.releasechimps.org/mission/end-chimpanzee-research/ country-bans/ (Accessed 19.10.10).
9. Bradshaw, G.A., Capaldo, T., Lindner, L. & Grow, G. (2008). Building an inner sanctuary: Complex PTSD in chimpanzees. Journal of Trauma Dissociation 9, 9-34.
10. Bradshaw, G.A., Capaldo, T., Lindner, L. & Grow, G. (2009). Developmental context effects on bi-cultural post-trauma self repair in chimpanzees. Developmental Psychology 45, 1376-1388.
11. Sauer, U.G. (2000). Reasons for not using primates in research. [German.] ALTEX 17, 217-220.
12. Thew, M. (2002). Are results of primate research worth the suffering it causes? Nature, London 418, 273.
13. Bailey, J. (2008). An assessment of the role of chimpanzees in AIDS vaccine research. ATLA 36, 381-428.
14. Bailey, J., Balcombe, J. & Capaldo, T. (2007). Chimpanzee Research: An Examination of Its Contribution to Biomedical Knowledge and Efficacy in Combating Human Diseases, 47pp. Boston, MA, USA: New England Anti-Vivisection Society (Project R&R). Available at: http://www.releasechimps.org/pdfs/ chimp-efficacy-paper-main.pdf (Accessed 19.10.10).
15. Knight, A. (2007). The poor contribution of chimpanzee experiments to biomedical progress. Journal of Applied Animal Welfare Science 10, 281-308.
16. de Kok, W. (2002). Dutch Lab Chimps to be Retired. Summerville, SC, USA: International Primate Protection League. Available at: http://www.ippl.org/2002- dutch-chimps.php (Accessed 09.12.10).
17. Vermij, P. (2003). Europe's last research chimps to retire. Nature Medicine 9, 981.
18. Bailey, J. (2010). An assessment of the use of chimpanzees in hepatitis C research past, present and future: 1. Validity of the chimpanzee model. ATLA 38, 387-418.
19. Houghton, M. & Abrignani, S. (2005). Prospects for a vaccine against the hepatitis C virus. Nature, London 436, 961-966. (Pubitemid 41191672)
20. Forns, X., Bukh, J. & Purcell, R.H. (2002). The challenge of developing a vaccine against hepatitis C virus. Journal of Hepatology 37, 684-695. (Pubitemid 35305553)
21. Bukh, J., Forns, X., Emerson, S.U. & Purcell, R.H. (2001). Studies of hepatitis C virus in chimpanzees and their importance for vaccine development. Intervirology 44, 132-142. (Pubitemid 32757391)
22. Bukh, J. (2004). A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39, 1469-1475.
23. Elmowalid, G.A., Qiao, M., Jeong, S-H., Borg, B.B., Baumert, T.F., Sapp, R.K., Hu, Z., Murthy, K. & Liang, T.J. (2007). Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proceedings of the National Academy of Sciences of the USA 104, 8427-8432. (Pubitemid 47175504)
24. Lanford, R.E., Bigger, C., Bassett, S. & Klimpel, G. (2001). The chimpanzee model of hepatitis C virus infections. ILAR Journal 42, 117-126. (Pubitemid 33708703)
25. Bartenschlager, R. & Lohmann, V. (2001). Novel cell culture systems for the hepatitis C virus. Antiviral Research 52, 1-17. (Pubitemid 32800687)
26. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. & Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science, New York 285, 110-113. (Pubitemid 29307577)
27. Brass, V., Moradpour, D. & Blum, H.E. (2007). Hepatitis C virus infection: In vivo and in vitro models. Journal of Viral Hepatitis 14, Suppl. 1, 64-67.
28. Lazaro, C.A., Chang, M., Tang, W., Campbell, J., Sullivan, D.G., Gretch, D.R., Corey, L., Coombs, R.W. & Fausto, N. (2007). Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. American Journal of Pathology 170, 478-489. (Pubitemid 47339385)
29. Gallo, R.C. (1993). Virus Hunting: Aids, Cancer, and the Human Retrovirus: A Story of Scientific Discovery, 368pp. New York, NY, USA: Basic Books.
30. Enders, J.F. & Peebles, T.C. (1954). Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proceedings of the Society for Experimental Biology & Medicine 86, 277-286.
31. Asselah, T., Benhamou, Y. & Marcellin, P. (2009). Protease and polymerase inhibitors for the treatment of hepatitis C. Liver International 29, Suppl. 1, 57-67.
32. Duverlie, G. & Wychowski, C. (2007). Cell culture systems for the hepatitis C virus. World Journal of Gastroenterology 13, 2442-2445. (Pubitemid 46929499)
33. Regeard, M., Lepere, C., Trotard, M., Gripon, P. & Le Seyec, J. (2007). Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle. FEBS Journal 274, 4705-4718. (Pubitemid 47353139)
34. Sheehy, P., Mullan, B., Moreau, I., Kenny-Walsh, E., Shanahan, F., Scallan, M. & Fanning, L.J. (2007). In vitro replication models for the hepatitis C virus. Journal of Viral Hepatitis 14, 2-10.
35. Iacovacci, S., Manzin, A., Barca, S., Sargiacomo, M., Serafino, A., Valli, M.B., Macioce, G., Hassan, H.J., Ponzetto, A., Clementi, M., Peschle, C. & Carloni, G. (1997). Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 26, 1328-1337. (Pubitemid 27509321)
36. Iacovacci, S., Sargiacomo, M., Parolini, I., Ponzetto, A., Peschle, C. & Carloni, G. (1993). Replication and multiplication of hepatitis C virus genome in human foetal liver cells. Research in Virology 144, 275-279. (Pubitemid 23247315)
37. Rumin, S., Berthillon, P., Tanaka, E., Kiyosawa, K., Trabaud, M.A., Bizollon, T., Gouillat, C., Gripon, P., Guguen-Guillouzo, C., Inchauspé, G. & Trepo, C. (1999). Dynamic analysis of hepatitis C virus replication and quasispecies selection in longterm cultures of adult human hepatocytes infected in vitro. Journal of General Virology 80, 3007-3018. (Pubitemid 29504674)
38. Fournier, C., Sureau, C., Coste, J., Ducos, J., Pageaux, G., Larrey, D., Domergue, J. & Maurel, P. (1998). In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. Journal of General Virology 79, 2367-2374.
39. Cribier, B., Schmitt, C., Bingen, A., Kirn, A. & Keller, F. (1995). In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. Journal of General Virology 76, 2485-2491.
40. Shimizu, Y.K., Iwamoto, A., Hijikata, M., Purcell, R.H. & Yoshikura, H. (1992). Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proceedings of the National Academy of Sciences of the USA 89, 5477-5481.
41. Kato, N., Nakazawa, T., Mizutani, T. & Shimotohno, K. (1995). Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochemical & Biophysical Research Communications 206, 863-869.
42. Shimizu, Y.K., Purcell, R.H. & Yoshikura, H. (1993). Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proceedings of the National Academy of Sciences of the USA 90, 6037-6041. (Pubitemid 23191449)
43. Nakajima, N., Hijikata, M., Yoshikura, H. & Shimizu, Y.K. (1996). Characterization of long-term cultures of hepatitis C virus. Journal of Virology 70, 3325-3329. (Pubitemid 26121957)
44. Seipp, S., Mueller, H.M., Pfaff, E., Stremmel, W., Theilmann, L. & Goeser, T. (1997). Establishment of persistent hepatitis C virus infection and replication in vitro. Journal of General Virology 78, 2467-2476. (Pubitemid 27469988)
45. Kato, N., Ikeda, M., Mizutani, T., Sugiyama, K., Noguchi, M., Hirohashi, S. & Shimotohno, K. (1996). Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Japanese Journal of Cancer Research 87, 787-792. (Pubitemid 26335804)
46. Ito, T., Mukaigawa, J., Zuo, J., Hirabayashi, Y., Mitamura, K. & Yasui, K. (1996). Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. Journal of General Virology 77, 1043-1054. (Pubitemid 26142340)
47. Muller, H.M., Pfaff, E., Goeser, T., Kallinowski, B., Solbach, C. & Theilmann, L. (1993). Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. Journal of General Virology 74, 669-676. (Pubitemid 23113370)
48. Molina, S., Castet, V., Fournier-Wirth, C., Pichard-Garcia, L., Avner, R., Harats, D., Roitelman, J., Barbaras, R., Graber, P., Ghersa, P., Smolarsky, M., Funaro, A., Malavasi, F., Larrey, D., Coste, J., Fabre, J.M., Sa-Cunha, A. & Maurel, P. (2007). The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. Journal of Hepatology 46, 411-419. (Pubitemid 46201721)
49. Sung, V.M., Shimodaira, S., Doughty, A.L., Picchio, G.R., Can, H., Yen, T.S., Lindsay, K.L., Levine, A.M. & Lai, M.M. (2003). Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: The apoptotic effects of virus infection. Journal of Virology 77, 2134-2146. (Pubitemid 36110026)
50. Gale, M.J. & Beard, M.R. (2001). Molecular clones of hepatitis C virus: Applications to animal models. ILAR Journal 42, 139-151.
51. Kolykhalov, A.A., Agapov, E.V., Blight, K.J., Mihalik, K., Feinstone, S.M. & Rice, C.M. (1997). Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science, New York 277, 570-574. (Pubitemid 27369006)
52. Yanagi, M., Purcell, R.H., Emerson, S.U. & Bukh, J. (1997). Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proceedings of the National Academy of Sciences of the USA 94, 8738-8743. (Pubitemid 27335109)
53. Moormann, R.J., van Gennip, H.G., Miedema, G.K., Hulst, M.M. & van Rijn, P.A. (1996). Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus. Journal of Virology 70, 763-770. (Pubitemid 26028991)
54. Bartenschlager, R. (2006). Hepatitis C virus molecular clones: From cDNA to infectious virus particles in cell culture. Current Opinion in Microbiology 9, 416-422.
55. Higashi, Y., Kakumu, S., Yoshioka, K., Wakita, T., Mizokami, M., Ohba, K., Ito, Y., Ishikawa, T., Takayanagi, M. & Nagai, Y. (1993). Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197, 659-668.
56. Yagi, S., Mori, K., Tanaka, E., Matsumoto, A., Sunaga, F., Kiyosawa, K. & Yamaguchi, K. (2005). Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients. Journal of Medical Virology 77, 399-413. (Pubitemid 41395871)
57. Yoo, B.J., Selby, M.J., Choe, J., Suh, B.S., Choi, S.H., Joh, J.S., Nuovo, G.J., Lee, H.S., Houghton, M. & Han, J.H. (1995). Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. Journal of Virology 69, 32-38.
58. Dash, S., Halim, A.B., Tsuji, H., Hiramatsu, N. & Gerber, M.A. (1997). Transfection of HepG2 cells with infectious hepatitis C virus genome. American Journal of Pathology 151, 363-373. (Pubitemid 27330057)
59. Bartenschlager, R. & Sparacio, S. (2007). Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Research 127, 195-207. (Pubitemid 47058197)
60. Myung, J., Khalap, N., Kalkeri, G., Garry, R. & Dash, S. (2001). Inducible model to study negative strand RNA synthesis and assembly of hepatitis C virus from a full-length cDNA clone. Journal of Virological Methods 94, 55-67. (Pubitemid 32411478)
61. Lim, S.P., Soo, H.M., Tan, Y.H., Brenner, S., Horstmann, H., MacKenzie, J.M., Ng, M.L., Lim, S.G. & Hong, W. (2002). Inducible system in human hepatoma cell lines for hepatitis C virus production. Virology 303, 79-99. (Pubitemid 36027167)
62. Moradpour, D., Wakita, T., Wands, J.R. & Blum, H.E. (1998). Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. Biochemical & Biophysical Research Communications 246, 920-924. (Pubitemid 28420958)
63. Moradpour, D., Kary, P., Rice, C.M. & Blum, H.E. (1998). Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28, 192-201. (Pubitemid 28300001)
64. Qi, Z.T., Kalkeri, G., Hanible, J., Prabhu, R., Bastian, F., Garry, R.F. & Dash, S. (2003). Stemloop structures II-IV of the 5 untranslated sequences are required for the expression of the full-length hepatitis C virus genome. Archives of Virology 148, 449-467. (Pubitemid 36302664)
65. Kalkeri, G., Khalap, N., Akhter, S., Garry, R.F., Fermin, C.D. & Dash, S. (2001). Hepatitis C viral proteins affect cell viability and membrane permeability. Experimental & Molecular Pathology 71, 194-208. (Pubitemid 34060094)
66. Huang, Y., Uchiyama, Y., Fujimura, T., Kanamori, H., Doi, T., Takamizawa, A., Hamakubo, T. & Kodama, T. (2001). A human hepatoma cell line expressing hepatitis C virus nonstructural proteins tightly regulated by tetracycline. Biochemical & Biophysical Research Communications 281, 732-740. (Pubitemid 32917862)
67. Heim, M.H., Moradpour, D. & Blum, H.E. (1999). Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. Journal of Virology 73, 8469-8475. (Pubitemid 29441710)
68. Prabhu, R., Joshi, V., Garry, R.F., Bastian, F., Haque, S., Regenstein, F., Thung, S. & Dash, S. (2004). Interferon alpha-2b inhibits negativestrand RNA and protein expression from fulllength HCV1a infectious clone. Experimental & Molecular Pathology 76, 242-252. (Pubitemid 38569786)
69. Chung, R.T., He, W., Saquib, A., Contreras, A.M., Xavier, R.J., Chawla, A., Wang, T.C. & Schmidt, E.V. (2001). Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system. Proceedings of the National Academy of Sciences of the USA 98, 9847-9852. (Pubitemid 32769392)
70. Harada, T., Kim, D.W., Sagawa, K., Suzuki, T., Takahashi, K., Saito, I., Matsuura, Y. & Miyamura, T. (1995). Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral cDNA. Journal of General Virology 76, 1215-1221.
71. Schmidt-Mende, J., Bieck, E., Hugle, T., Penin, F., Rice, C.M., Blum, H.E. & Moradpour, D. (2001). Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. Journal of Biological Chemistry 276, 44,052-44,063.
72. Wolk, B., Sansonno, D., Krausslich, H.G., Dammacco, F., Rice, C.M., Blum, H.E. & Moradpour, D. (2000). Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. Journal of Virology 74, 2293-2304. (Pubitemid 30091484)
73. Bartenschlager, R., Frese, M. & Pietschmann, T. (2004). Novel insights into hepatitis C virus replication and persistence. Advances in Virus Research 63, 71-180. (Pubitemid 39752303)
74. Lindenbach, B.D. & Rice, C.M. (2005). Unravelling hepatitis C virus replication from genome to function. Nature, London 436, 933-938. (Pubitemid 41191668)
75. De Francesco, R. & Migliaccio, G. (2005). Challenges and successes in developing new therapies for hepatitis C. Nature, London 436, 953-960. (Pubitemid 41191671)
76. Khromykh, A.A. & Westaway, E.G. (1997). Subgenomic replicons of the flavivirus Kunjin: Construction and applications. Journal of Virology 71, 1497-1505. (Pubitemid 27030325)
77. Behrens, S.E., Grassmann, C.W., Thiel, H.J., Meyers, G. & Tautz, N. (1998). Characterization of an autonomous subgenomic pestivirus RNA replicon. Journal of Virology 72, 2364-2372. (Pubitemid 28100797)
78. Kaplan, G. & Racaniello, V.R. (1988). Construction and characterization of poliovirus subgenomic replicons. Journal of Virology 62, 1687-1696.
79. Blight, K.J., Kolykhalov, A.A. & Rice, C.M. (2000). Efficient initiation of HCV RNA replication in cell culture. Science, New York 290, 1972-1974.
80. Lohmann, V., Korner, F., Dobierzewska, A. & Bartenschlager, R. (2001). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. Journal of Virology 75, 1437-1449.
81. Blight, K.J., McKeating, J.A., Marcotrigiano, J. & Rice, C.M. (2003). Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. Journal of Virology 77, 3181-3190. (Pubitemid 36228102)
82. Yi, M. & Lemon, S.M. (2004). Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. Journal of Virology 78, 7904-7915. (Pubitemid 38944276)
83. Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M. & Wakita, T. (2003). Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808-1817. (Pubitemid 37500445)
84. Lohmann, V., Hoffmann, S., Herian, U., Penin, F. & Bartenschlager, R. (2003). Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. Journal of Virology 77, 3007-3019. (Pubitemid 36228086)
85. Blight, K.J., McKeating, J.A. & Rice, C.M. (2002). Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. Journal of Virology 76, 13,001-13,014.
86. Friebe, P., Boudet, J., Simorre, J.P. & Bartenschlager, R. (2005). Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication. Journal of Virology 79, 380-392. (Pubitemid 39648391)
87. Yi, M., Villanueva, R.A., Thomas, D.L., Wakita, T. & Lemon, S.M. (2006). Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proceedings of the National Academy of Sciences of the USA 103, 2310-2315. (Pubitemid 43271666)
88. Adair, R., Patel, A.H., Corless, L., Griffin, S., Rowlands, D. & McCormick, C.J. (2009). Expression of HCV structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA. Journal of General Virology 90, 833-842.
89. Ishii, K., Murakami, K., Hmwe, S.S., Zhang, B., Li, J., Shirakura, M., Morikawa, K., Suzuki, R., Miyamura, T., Wakita, T. & Suzuki, T. (2008). Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. Biochemical & Biophysical Research Communications 371, 446-450.
90. Steinmann, E., Brohm, C., Kallis, S., Bartenschlager, R. & Pietschmann, T. (2008). Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. Journal of Virology 82, 7034-7046. (Pubitemid 351977723)
91. Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R.M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R. & Vitelli, A. (2002). The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO Journal 21, 5017-5025.
92. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.J., Houghton, M., Rosa, D., Grandi, G. & Abrignani, S. (1998). Binding of hepatitis C virus to CD81. Science, New York 282, 938-941. (Pubitemid 28507525)
93. Flint, M., Thomas, J.M., Maidens, C.M., Shotton, C., Levy, S., Barclay, W.S. & McKeating, J.A. (1999). Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. Journal of Virology 73, 6782-6790. (Pubitemid 29327861)
94. Baumert, T.F., Ito, S., Wong, D.T. & Liang, T.J. (1998). Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. Journal of Virology 72, 3827-3836. (Pubitemid 28188682)
95. Baumert, T.F., Wellnitz, S., Aono, S., Satoi, J., Herion, D., Tilman Gerlach, J., Pape, G.R., Lau, J.Y., Hoofnagle, J.H., Blum, H.E. & Liang, T.J. (2000). Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology 32, 610-617.
96. Owsianka, A., Clayton, R.F., Loomis-Price, L.D., McKeating, J.A. & Patel, A.H. (2001). Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. Journal of General Virology 82, 1877-1883. (Pubitemid 32707551)
97. Triyatni, M., Vergalla, J., Davis, A.R., Hadlock, K.G., Foung, S.K. & Liang, T.J. (2002). Structural features of envelope proteins on hepatitis C viruslike particles as determined by anti-envelope monoclonal antibodies and CD81 binding. Virology 298, 124-132. (Pubitemid 34734886)
98. Triyatni, M., Saunier, B., Maruvada, P., Davis, A.R., Ulianich, L., Heller, T., Patel, A., Kohn, L.D. & Liang, T.J. (2002). Interaction of hepatitis C virus-like particles and cells: A model system for studying viral binding and entry. Journal of Virology 76, 9335-9344. (Pubitemid 34919891)
99. Wellnitz, S., Klumpp, B., Barth, H., Ito, S., Depla, E., Dubuisson, J., Blum, H.E. & Baumert, T.F. (2002). Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines. Journal of Virology 76, 1181-1193.
100. Agnello, V., Abel, G., Elfahal, M., Knight, G.B. & Zhang, Q.X. (1999). Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proceedings of the National Academy of Sciences of the USA 96, 12,766-12,771.
101. Barth, H., Schafer, C., Adah, M.I., Zhang, F., Linhardt, R.J., Toyoda, H., Kinoshita-Toyoda, A., Toida, T., Van Kuppevelt, T.H., Depla, E., Von Weizsacker, F., Blum, H.E. & Baumert, T.F. (2003). Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. Journal of Biological Chemistry 278, 41,003-41,012.
102. Barth, H., Schnober, E.K., Zhang, F., Linhardt, R.J., Depla, E., Boson, B., Cosset, F.L., Patel, A.H., Blum, H.E. & Baumert, T.F. (2006). Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. Journal of Virology 80, 10,579-10,590.
103. Evans, M.J., von Hahn, T., Tscherne, D.M., Syder, A.J., Panis, M., Wolk, B., Hatziioannou, T., McKeating, J.A., Bieniasz, P.D. & Rice, C.M. (2007). Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature, London 446, 801-805. (Pubitemid 46582027)
104. Barth, H., Ulsenheimer, A., Pape, G.R., Diepolder, H.M., Hoffmann, M., Neumann-Haefelin, C., Thimme, R., Henneke, P., Klein, R., Paranhos-Baccala, G., Depla, E., Liang, T.J., Blum, H.E. & Baumert, T.F. (2005). Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood 105, 3605-3614.
105. Fang, X., Zeisel, M.B., Wilpert, J., Gissler, B., Thimme, R., Kreutz, C., Maiwald, T., Timmer, J., Kern, W.V., Donauer, J., Geyer, M., Walz, G., Depla, E., von Weizsacker, F., Blum, H.E. & Baumert, T.F. (2006). Host cell responses induced by hepatitis C virus binding. Hepatology 43, 1326-1336. (Pubitemid 43980112)
106. Bartosch, B., Dubuisson, J. & Cosset, F.L. (2003). Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. Journal of Experimental Medicine 197, 633-642. (Pubitemid 36314658)
107. Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C.M. & McKeating, J.A. (2003). Hepatitis C virus glycoproteins mediate pHdependent cell entry of pseudotyped retroviral particles. Proceedings of the National Academy of Sciences of the USA 100, 7271-7276. (Pubitemid 36706428)
108. Matsuura, Y., Tani, H., Suzuki, K., Kimura-Someya, T., Suzuki, R., Aizaki, H., Ishii, K., Moriishi, K., Robison, C.S., Whitt, M.A. & Miyamura, T. (2001). Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286, 263-275. (Pubitemid 32721803)
109. Barth, H., Liang, T.J. & Baumert, T.F. (2006). Hepatitis C virus entry: Molecular biology and clinical implications. Hepatology 44, 527-535.
110. Cocquerel, L., Voisset, C. & Dubuisson, J. (2006). Hepatitis C virus entry: Potential receptors and their biological functions. Journal of General Virology 87, 1075-1084.
111. Bartosch, B. & Cosset, F.L. (2006). Cell entry of hepatitis C virus. Virology 348, 1-12.
112. Zeisel, M.B. & Baumert, T.F. (2006). Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied research. Journal of Hepatology 44, 436-439. (Pubitemid 43069231)
113. Connelly, M.A. & Williams, D.L. (2004). SR-BI and HDL cholesteryl ester metabolism. Endocrine Research 30, 697-703. (Pubitemid 40070155)
114. Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A. & Cosset, F.L. (2003). Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. Journal of Biological Chemistry 278, 41,624-41,630.
115. von Hahn, T., Lindenbach, B.D., Boullier, A., Quehenberger, O., Paulson, M., Rice, C.M. & McKeating, J.A. (2006). Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 43, 932-942. (Pubitemid 43724618)
116. Voisset, C., Callens, N., Blanchard, E., Op de Beeck, A., Dubuisson, J. & Vu-Dac, N. (2005). High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. Journal of Biological Chemistry 280, 7793-7799. (Pubitemid 40349673)
117. Voisset, C., Op de Beeck, A., Horellou, P., Dreux, M., Gustot, T., Duverlie, G., Cosset, F.L., Vu-Dac, N. & Dubuisson, J. (2006). High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. Journal of General Virology 87, 2577-2581.
118. Bartosch, B., Verney, G., Dreux, M., Donot, P., Morice, Y., Penin, F., Pawlotsky, J.M., Lavillette, D. & Cosset, F.L. (2005). An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and highdensity lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. Journal of Virology 79, 8217-8229. (Pubitemid 40853525)
119. Meunier, J.C., Engle, R.E., Faulk, K., Zhao, M., Bartosch, B., Alter, H., Emerson, S.U., Cosset, F.L., Purcell, R.H. & Bukh, J. (2005). Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proceedings of the National Academy of Sciences of the USA 102, 4560-4565. (Pubitemid 40397151)
120. Bartosch, B., Bukh, J., Meunier, J.C., Granier, C., Engle, R.E., Blackwelder, W.C., Emerson, S.U., Cosset, F.L. & Purcell, R.H. (2003). In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes. Proceedings of the National Academy of Sciences of the USA 100, 14,199-14,204.
121. Tanaka, T., Kato, N., Cho, M.J. & Shimotohno, K. (1995). A novel sequence found at the 3 terminus of hepatitis C virus genome. Biochemical & Biophysical Research Communications 215, 744-749.
122. Logvinoff, C., Major, M.E., Oldach, D., Heyward, S., Talal, A., Balfe, P., Feinstone, S.M., Alter, H., Rice, C.M. & McKeating, J.A. (2004). Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proceedings of the National Academy of Sciences of the USA 101, 10,149-10,154.
123. Lavillette, D., Morice, Y., Germanidis, G., Donot, P., Soulier, A., Pagkalos, E., Sakellariou, G., Intrator, L., Bartosch, B., Pawlotsky, J.M. & Cosset, F.L. (2005). Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. Journal of Virology 79, 6023-6034. (Pubitemid 40617208)
124. Johansson, D.X., Voisset, C., Tarr, A.W., Aung, M., Ball, J.K., Dubuisson, J. & Persson, M.A. (2007). Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proceedings of the National Academy of Sciences of the USA 104, 16,269-16,274.
125. Zhang, K., Tan, W.J., Deng, Y., Li, J., Wu, X.B. & Ruan, L. (2008). Development of infectious pseudoparticle harboring three subtypes hepatitis C virus glycoproteins and their application in neutralization assays. [Chinese.] Bing Du Xue Bao 24, 287-294.
126. Flint, M., Maidens, C., Loomis-Price, L.D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S. & McKeating, J.A. (1999). Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. Journal of Virology 73, 6235-6244. (Pubitemid 29327798)
127. Zhang, J., Randall, G., Higginbottom, A., Monk, P., Rice, C.M. & McKeating, J.A. (2004). CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. Journal of Virology 78, 1448-1455. (Pubitemid 38095855)
128. Cormier, E.G., Tsamis, F., Kajumo, F., Durso, R.J., Gardner, J.P. & Dragic, T. (2004). CD81 is an entry coreceptor for hepatitis C virus. Proceedings of the National Academy of Sciences of the USA 101, 7270-7274. (Pubitemid 38638022)
129. Op de Beeck, A., Voisset, C., Bartosch, B., Ciczora, Y., Cocquerel, L., Keck, Z., Foung, S., Cosset, F.L. & Dubuisson, J. (2004). Characterization of functional hepatitis C virus envelope glycoproteins. Journal of Virology 78, 2994-3002. (Pubitemid 38314357)
130. Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C. & Rouille, Y. (2006). Hepatitis C virus entry depends on clathrinmediated endocytosis. Journal of Virology 80, 6964-6972. (Pubitemid 44025195)
131. Meertens, L., Bertaux, C. & Dragic, T. (2006). Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. Journal of Virology 80, 11,571-11,578.
132. Codran, A., Royer, C., Jaeck, D., Bastien-Valle, M., Baumert, T.F., Kieny, M.P., Pereira, C.A. & Martin, J.P. (2006). Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. Journal of General Virology 87, 2583-2593.
133. Lozach, P.Y., Lortat-Jacob, H., de Lacroix de Lavalette, A., Staropoli, I., Foung, S., Amara, A., Houles, C., Fieschi, F., Schwartz, O., Virelizier, J.L., Arenzana-Seisdedos, F. & Altmeyer, R. (2003). DCSIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. Journal of Biological Chemistry 278, 20,358-20,366.
134. Gardner, J.P., Durso, R.J., Arrigale, R.R., Donovan, G.P., Maddon, P.J., Dragic, T. & Olson, W.C. (2003). L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proceedings of the National Academy of Sciences of the USA 100, 4498-4503. (Pubitemid 36457759)
135. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.G., Mizokami, M., Bartenschlager, R. & Liang, T.J. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine 11, 791-796. (Pubitemid 41021213)
136. Kato, T., Furusaka, A., Miyamoto, M., Date, T., Yasui, K., Hiramoto, J., Nagayama, K., Tanaka, T. & Wakita, T. (2001). Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. Journal of Medical Virology 64, 334-339. (Pubitemid 32565130)
137. Kato, T., Date, T., Miyamoto, M., Zhao, Z., Mizokami, M. & Wakita, T. (2005). Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. Journal of Virology 79, 592-596. (Pubitemid 39648411)
138. Date, T., Kato, T., Miyamoto, M., Zhao, Z., Yasui, K., Mizokami, M. & Wakita, T. (2004). Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. Journal of Biological Chemistry 279, 22,371-22,376.
139. Bartenschlager, R. & Pietschmann, T. (2005). Efficient hepatitis C virus cell culture system: What a difference the host cell makes. Proceedings of the National Academy of Sciences of the USA 102, 9739-9740. (Pubitemid 40993637)
140. Lindenbach, B.D., Evans, M.J., Syder, A.J., Wolk, B., Tellinghuisen, T.L., Liu, C.C., Maruyama, T., Hynes, R.O., Burton, D.R., McKeating, J.A. & Rice, C.M. (2005). Complete replication of hepatitis C virus in cell culture. Science, New York 309, 623-626. (Pubitemid 41033648)
141. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D.R., Wieland, S.F., Uprichard, S.L., Wakita, T. & Chisari, F.V. (2005). Robust hepatitis C virus infection in vitro. Proceedings of the National Academy of Sciences of the USA 102, 9294-9299. (Pubitemid 40923557)
142. Pietschmann, T., Kaul, A., Koutsoudakis, G., Shavinskaya, A., Kallis, S., Steinmann, E., Abid, K., Negro, F., Dreux, M., Cosset, F.L. & Bartenschlager, R. (2006). Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proceedings of the National Academy of Sciences of the USA 103, 7408-7413. (Pubitemid 43727846)
143. Yi, M., Ma, Y., Yates, J. & Lemon, S.M. (2007). Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. Journal of Virology 81, 629-638. (Pubitemid 46067890)
144. Lanford, R.E., Guerra, B. & Lee, H. (2006). Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain. Virology 355, 192-202. (Pubitemid 44692777)
145. Graham, D.J., Stahlhut, M., Flores, O., Olsen, D.B., Hazuda, D.J., Lafemina, R.L. & Ludmerer, S.W. (2006). A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background. Antiviral Research 69, 24-30. (Pubitemid 41790478)
146. Binder, M., Quinkert, D., Bochkarova, O., Klein, R., Kezmic, N., Bartenschlager, R. & Lohmann, V. (2007). Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. Journal of Virology 81, 5270-5283. (Pubitemid 46744436)
147. Bungyoku, Y., Shoji, I., Makine, T., Adachi, T., Hayashida, K., Nagano-Fujii, M., Ide, Y.H., Deng, L. & Hotta, H. (2009). Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. Journal of General Virology 90, 1681-1691.
148. Scheel, T.K., Gottwein, J.M., Jensen, T.B., Prentoe, J.C., Hoegh, A.M., Alter, H.J., Eugen-Olsen, J. & Bukh, J. (2008). Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proceedings of the National Academy of Sciences of the USA 105, 997-1002. (Pubitemid 351282070)
149. Kato, T., Matsumura, T., Heller, T., Saito, S., Sapp, R.K., Murthy, K., Wakita, T. & Liang, T.J. (2007). Production of infectious hepatitis C virus of various genotypes in cell cultures. Journal of Virology 81, 4405-4411. (Pubitemid 46668637)
150. Grove, J., Huby, T., Stamataki, Z., Vanwolleghem, T., Meuleman, P., Farquhar, M., Schwarz, A., Moreau, M., Owen, J.S., Leroux-Roels, G., Balfe, P. & McKeating, J.A. (2007). Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. Journal of Virology 81, 3162-3169. (Pubitemid 46456625)
151. Koutsoudakis, G., Herrmann, E., Kallis, S., Bartenschlager, R. & Pietschmann, T. (2007). The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. Journal of Virology 81, 588-598. (Pubitemid 46067886)
152. Akazawa, D., Date, T., Morikawa, K., Murayama, A., Miyamoto, M., Kaga, M., Barth, H., Baumert, T.F., Dubuisson, J. & Wakita, T. (2007). CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. Journal of Virology 81, 5036-5045.
153. Kapadia, S.B., Barth, H., Baumert, T., McKeating, J.A. & Chisari, F.V. (2007). Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. Journal of Virology 81, 374-383. (Pubitemid 44975176)
154. Catanese, M.T., Graziani, R., von Hahn, T., Moreau, M., Huby, T., Paonessa, G., Santini, C., Luzzago, A., Rice, C.M., Cortese, R., Vitelli, A. & Nicosia, A. (2007). High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. Journal of Virology 81, 8063-8071. (Pubitemid 47101492)
155. Meunier, J-C., Russell, R.S., Engle, R.E., Faulk, K.N., Purcell, R.H. & Emerson, S.U. (2008). Apolipoprotein c1 association with hepatitis C virus. Journal of Virology 82, 9647-9656.
156. Berger, K.L., Cooper, J.D., Heaton, N.S., Yoon, R., Oakland, T.E., Jordan, T.X., Mateu, G., Grakoui, A. & Randall, G. (2009). Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proceedings of the National Academy of Sciences of the USA 106, 7577-7582.
157. Seeff, L.B. (2009). The history of the "natural history" of hepatitis C (1968-2009). Liver International 29, Suppl. 1, 89-99.
158. Maillard, P., Krawczynski, K., Nitkiewicz, J., Bronnert, C., Sidorkiewicz, M., Gounon, P., Dubuisson, J., Faure, G., Crainic, R. & Budkowska, A. (2001). Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. Journal of Virology 75, 8240-8250. (Pubitemid 32743696)
159. Petit, M.A., Lievre, M., Peyrol, S., De Sequeira, S., Berthillon, P., Ruigrok, R.W. & Trepo, C. (2005). Enveloped particles in the serum of chronic hepatitis C patients. Virology 336, 144-153. (Pubitemid 40693949)
160. Roingeard, P., Hourioux, C., Blanchard, E., Brand, D. & Ait-Goughoulte, M. (2004). Hepatitis C virus ultrastructure and morphogenesis. Biology of the Cell 96, 103-108. (Pubitemid 38391192)
161. Andre, P., Perlemuter, G., Budkowska, A., Brechot, C. & Lotteau, V. (2005). Hepatitis C virus particles and lipoprotein metabolism. Seminars in Liver Disease 25, 93-104. (Pubitemid 40322354)
162. Kaito, M., Watanabe, S., Tsukiyama-Kohara, K., Yamaguchi, K., Kobayashi, Y., Konishi, M., Yokoi, M., Ishida, S., Suzuki, S. & Kohara, M. (1994). Hepatitis C virus particle detected by immunoelectron microscopic study. Journal of General Virology 75, 1755-1760. (Pubitemid 24211260)
163. Prince, A.M., Huima-Byron, T., Parker, T.S. & Levine, D.M. (1996). Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. Journal of Viral Hepatitis 3, 11-17. (Pubitemid 126734193)
164. Diedrich, G. (2006). How does hepatitis C virus enter cells? The FEBS Journal 273, 3871-3885.
165. Thomssen, R., Bonk, S. & Thiele, A. (1993). Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Medical Microbiology & Immunology 182, 329-334. (Pubitemid 24011208)
166. Thomssen, R., Bonk, S., Propfe, C., Heermann, K.H., Kochel, H.G. & Uy, A. (1992). Association of hepatitis C virus in human sera with beta-lipoprotein. Medical Microbiology & Immunology 181, 293-300.
167. Miyamoto, H., Okamoto, H., Sato, K., Tanaka, T. & Mishiro, S. (1992). Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. Journal of General Virology 73, 715-718.
168. Kono, Y., Hayashida, K., Tanaka, H., Ishibashi, H. & Harada, M. (2003). High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. Journal of Medical Virology 70, 42-48. (Pubitemid 36368863)
169. Nielsen, S.U., Bassendine, M.F., Burt, A.D., Martin, C., Pumeechockchai, W. & Toms, G.L. (2006). Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. Journal of Virology 80, 2418-2428. (Pubitemid 43271547)
170. Schettler, V., Monazahian, M., Wieland, E., Ramadori, G., Grunewald, R.W., Thomssen, R. & Muller, G.A. (2001). Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis. European Journal of Clinical Investigation 31, 154-155. (Pubitemid 32201195)
171. Hijikata, M., Shimizu, Y.K., Kato, H., Iwamoto, A., Shih, J.W., Alter, H.J., Purcell, R.H. & Yoshikura, H. (1993). Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes. Journal of Virology 67, 1953-1958. (Pubitemid 23088368)
172. Bradley, D., McCaustland, K., Krawczynski, K., Spelbring, J., Humphrey, C. & Cook, E.H. (1991). Hepatitis C virus: Buoyant density of the factor VIII-derived isolate in sucrose. Journal of Medical Virology 34, 206-208.
173. Trestard, A., Bacq, Y., Buzelay, L., Dubois, F., Barin, F., Goudeau, A. & Roingeard, P. (1998). Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient. Archives of Virology 143, 2241-2245. (Pubitemid 28560311)
174. Andre, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J.L., Sodoyer, M., Pol, S., Brechot, C., Paranhos-Baccala, G. & Lotteau, V. (2002). Characterization of low-and very-low-density hepatitis C virus RNA-containing particles. Journal of Virology 76, 6919-6928. (Pubitemid 41246207)
175. Huang, H., Sun, F., Owen, D.M., Li, W., Chen, Y., Gale, M.J. & Ye, J. (2007). Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proceedings of the National Academy of Sciences of the USA 104, 5848-5853. (Pubitemid 47175622)
176. Suzuki, T., Masaki, T. & Aizaki, H. (2008). Involvement of nonstructural protein 5A and lipids on production of hepatitis C virus particles. [Japanese.] Uirusu 58, 199-205.
177. Casiraghi, M.A., De Paschale, M., Romano, L., Biffi, R., Assi, A., Binelli, G. & Zanetti, A.R. (2004). Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 39, 90-96. (Pubitemid 38461471)
178. Meyer, M.F., Lehmann, M., Cornberg, M., Wiegand, J., Manns, M.P., Klade, C. & Wedemeyer, H. (2007). Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response. Virology Journal 4, 58.
179. Cox, A.L., Mosbruger, T., Lauer, G.M., Pardoll, D., Thomas, D.L. & Ray, S.C. (2005). Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42, 104-112. (Pubitemid 40911317)
180. Urbani, S., Amadei, B., Fisicaro, P., Tola, D., Orlandini, A., Sacchelli, L., Mori, C., Missale, G. & Ferrari, C. (2006). Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 44, 126-139. (Pubitemid 44049146)
181. Kaplan, D.E., Sugimoto, K., Newton, K., Valiga, M.E., Ikeda, F., Aytaman, A., Nunes, F.A., Lucey, M.R., Vance, B.A., Vonderheide, R.H., Reddy, K.R., McKeating, J.A. & Chang, K.M. (2007). Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 132, 654-666. (Pubitemid 46274664)
182. Timm, J., Lauer, G.M., Kavanagh, D.G., Sheridan, I., Kim, A.Y., Lucas, M., Pillay, T., Ouchi, K., Reyor, L.L., Schulze zur Wiesch, J., Gandhi, R.T., Chung, R.T., Bhardwaj, N., Klenerman, P., Walker, B.D. & Allen, T.M. (2004). CD8 epitope escape and reversion in acute HCV infection. Journal of Experimental Medicine 200, 1593-1604.
183. Neumann-Haefelin, C., McKiernan, S., Ward, S., Viazov, S., Spangenberg, H.C., Killinger, T., Baumert, T.F., Nazarova, N., Sheridan, I., Pybus, O., von Weizsacker, F., Roggendorf, M., Kelleher, D., Klenerman, P., Blum, H.E. & Thimme, R. (2006). Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 43, 563-572.
184. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J.C., Strazzera, A., Chien, D.Y., Munoz, S.J., Balestrieri, A., Purcell, R.H. & Alter, H.J. (2000). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science, New York 288, 339-344. (Pubitemid 30226196)
185. Rehermann, B., Chang, K.M., McHutchinson, J., Kokka, R., Houghton, M., Rice, C.M. & Chisari, F.V. (1996). Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. Journal of Virology 70, 7092-7102. (Pubitemid 26307425)
186. Nelson, D.R., Marousis, C.G., Davis, G.L., Rice, C.M., Wong, J., Houghton, M. & Lau, J.Y. (1997). The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. Journal of Immunology 158, 1473-1481. (Pubitemid 127469976)
187. Ray, S.C., Wang, Y.M., Laeyendecker, O., Ticehurst, J.R., Villano, S.A. & Thomas, D.L. (1999). Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy. Journal of Virology 73, 2938-2946. (Pubitemid 29135682)
188. Taylor, D.R., Shi, S.T., Romano, P.R., Barber, G.N. & Lai, M.M. (1999). Inhibition of the interferoninducible protein kinase PKR by HCV E2 protein. Science, New York 285, 107-110. (Pubitemid 29307576)
189. Gale, M.J.J., Korth, M.J., Tang, N.M., Tan, S.L., Hopkins, D.A., Dever, T.E., Polyak, S.J., Gretch, D.R. & Katze, M.G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227. (Pubitemid 27211852)
190. Chapel, H.M., Christie, J.M., Peach, V. & Chapman, R.W. (2001). Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clinical Immunology 99, 320-324.
191. Lai, M.E., Mazzoleni, A.P., Argiolu, F., De Virgilis, S., Balestrieri, A., Purcell, R.H., Cao, A. & Farci, P. (1994). Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343, 388-390. (Pubitemid 24049557)
192. Bjoro, K., Froland, S.S., Yun, Z., Samdal, H.H. & Haaland, T. (1994). Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. New England Journal of Medicine 331, 1607-1611. (Pubitemid 24372058)
193. Post, J.J., Pan, Y., Freeman, A.J., Harvey, C.E., White, P.A., Palladinetti, P., Haber, P.S., Marinos, G., Levy, M.H., Kaldor, J.M., Dolan, K.A., Ffrench, R.A., Lloyd, A.R. & Rawlinson, W.D. (2004). Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. Journal of Infectious Diseases 189, 1846-1855.
194. Meyer, M.F., Wedemeyer, H., Monazahian, M., Dreesman, J., Manns, M.P. & Lehmann, M. (2007). Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiology & Infection 135, 274-280. (Pubitemid 46322066)
195. Hassan, M., Selimovic, D., Ghozlan, H. & Abdelkader, O. (2009). Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways. Hepatology 49, 1469-1482.
196. Phan, T., Beran, R.K., Peters, C., Lorenz, I. & Lindenbach, B.D. (2009). Hepatitis C virus NS2 protein contributes to virus particle assembly via opposing epistatic interactions with the E1-E2 glycoprotein and NS3-4A enzyme complexes. Journal of Virology 83, 8379-8395.
197. Vieyres, G., Angus, A.G., Haberstroh, A., Baumert, T.F., Dubuisson, J. & Patel, A.H. (2009). Rapid synchronization of hepatitis C virus infection by magnetic adsorption. Journal of Virological Methods 157, 69-79.
198. Cao, W., Sun, B., Feitelson, M.A., Wu, T., Tur-Kaspa, R. & Fan, Q. (2009). Hepatitis C virus targets overexpression of arginase I in hepatocarcinogenesis. International Journal of Cancer 124, 2886-2892.
199. Yamashita, T., Kaneko, S., Hashimoto, S., Sato, T., Nagai, S., Toyoda, N., Suzuki, T., Kobayashi, K. & Matsushima, K. (2001). Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma. Biochemical & Biophysical Research Communications 282, 647-654. (Pubitemid 32917921)
200. Jones, C.T., Murray, C.L., Eastman, D.K., Tassello, J. & Rice, C.M. (2007). Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. Journal of Virology 81, 8374-8383. (Pubitemid 47242811)
201. Jirasko, V., Montserret, R., Appel, N., Janvier, A., Eustachi, L., Brohm, C., Steinmann, E., Pietschmann, T., Penin, F. & Bartenschlager, R. (2008). Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. Journal of Biological Chemistry 283, 28,546-28,562.
202. Welbourn, S., Jirasko, V., Breton, V., Reiss, S., Penin, F., Bartenschlager, R. & Pause, A. (2009). Investigation of a role for lysine residues in nonstructural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly. Journal of General Virology 90, 1071-1080.
203. Yi, M., Ma, Y., Yates, J. & Lemon, S.M. (2009). Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathogens 5, e1000403.
204. Arumugaswami, V., Remenyi, R., Kanagavel, V., Sue, E.Y., Ngoc Ho, T., Liu, C., Fontanes, V., Dasgupta, A. & Sun, R. (2008). High-resolution functional profiling of hepatitis C virus genome. PLoS Pathogens 4, e1000182.
205. Wohnsland, A., Hofmann, W.P. & Sarrazin, C. (2007). Viral determinants of resistance to treatment in patients with hepatitis C. Clinical Microbiology Reviews 20, 23-38. (Pubitemid 46167766)
206. Katsarou, K., Serti, E., Tsitoura, P., Lavdas, A.A., Varaklioti, A., Pickl-Herk, A.M., Blaas, D., Oz-Arslan, D., Zhu, R., Hinterdorfer, P., Mavromara, P. & Georgopoulou, U. (2009). Green fluorescent protein-tagged HCV non-enveloped capsid like particles: Development of a new tool for tracking HCV core uptake. Biochimie 91, 903-915.
207. Vassilaki, N. & Mavromara, P. (2009). The HCV ARFP/F/core+1 protein: Production and functional analysis of an unconventional viral product. IUBMB Life 61, 739-752.
208. Asselah, T., Bieche, I., Sabbagh, A., Bedossa, P., Moreau, R., Valla, D., Vidaud, M. & Marcellin, P. (2009). Gene expression and hepatitis C virus infection. Gut 58, 846-858.
209. Huang, H., Shiffman, M.L., Cheung, R.C., Layden, T.J., Friedman, S., Abar, O.T., Yee, L., Chokkalingam, A.P., Schrodi, S.J., Chan, J., Catanese, J.J., Leong, D.U., Ross, D., Hu, X., Monto, A., McAllister, L.B., Broder, S., White, T., Sninsky, J.J. & Wright, T.L. (2006). Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 130, 1679-1687. (Pubitemid 43668836)
210. Huang, H., Shiffman, M.L., Friedman, S., Venkatesh, R., Bzowej, N., Abar, O.T., Rowland, C.M., Catanese, J.J., Leong, D.U., Sninsky, J.J., Layden, T.J., Wright, T.L., White, T. & Cheung, R.C. (2007). A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 46, 297-306. (Pubitemid 47344763)
211. Liu, H.C., Hicks, J. & Yoo, D. (2008). Proteomic dissection of viral pathogenesis. Developments in Biologicals 132, 43-53.
212. Vogt, M., Lang, T., Frosner, G., Klingler, C., Sendl, A.F., Zeller, A., Wiebecke, B., Langer, B., Meisner, H. & Hess, J. (1999). Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. New England Journal of Medicine 341, 866-870. (Pubitemid 29427048)
213. Deuffic-Burban, S., Poynard, T. & Valleron, A.J. (2002). Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. Journal of Viral Hepatitis 9, 114-122. (Pubitemid 36002474)
214. Minola, E., Prati, D., Suter, F., Maggiolo, F., Caprioli, F., Sonzogni, A., Fraquelli, M., Paggi, S. & Conte, D. (2002). Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99, 4588-4591. (Pubitemid 34627231)
215. Di Martino, V., Lebray, P., Myers, R.P., Pannier, E., Paradis, V., Charlotte, F., Moussalli, J., Thabut, D., Buffet, C. & Poynard, T. (2004). Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure. Hepatology 40, 1426-1433. (Pubitemid 39657018)
216. Wiese, M., Berr, F., Lafrenz, M., Porst, H. & Oesen, U. (2000). Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study. Hepatology 32, 91-96. (Pubitemid 30432371)
217. Kenny-Walsh, E. (1999). Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. New England Journal of Medicine 340, 1228-1233.
218. Sterling, R.K., Stravitz, R.T., Luketic, V.A., Sanyal, A.J., Contos, M.J., Mills, A.S. & Shiffman, M.L. (2004). A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans. Clinical Gastroenterology & Hepatology 2, 469-473. (Pubitemid 38698361)
219. Wiley, T.E., Brown, J. & Chan, J. (2002). Hepatitis C infection in African Americans: Its natural history and histological progression. American Journal of Gastroenterology 97, 700-706.
220. Tillmann, H.L., Chen, D.F., Trautwein, C., Kliem, V., Grundey, A., Berning-Haag, A., Boker, K., Kubicka, S., Pastucha, L., Stangel, W. & Manns, M.P. (2001). Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 48, 714-718. (Pubitemid 32378596)
221. Kuzushita, N., Hayashi, N., Moribe, T., Katayama, K., Kanto, T., Nakatani, S., Kaneshige, T., Tatsumi, T., Ito, A., Mochizuki, K., Sasaki, Y., Kasahara, A. & Hori, M. (1998). Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27, 240-244. (Pubitemid 28041560)
222. Promrat, K., McDermott, D.H., Gonzalez, C.M., Kleiner, D.E., Koziol, D.E., Lessie, M., Merrell, M., Soza, A., Heller, T., Ghany, M., Park, Y., Alter, H.J., Hoofnagle, J.H., Murphy, P.M. & Liang, T.J. (2003). Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124, 352-360. (Pubitemid 36169252)
223. Kanzler, S., Baumann, M., Schirmacher, P., Dries, V., Bayer, E., Gerken, G., Dienes, H.P. & Lohse, A.W. (2001). Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. Journal of Viral Hepatitis 8, 430-437. (Pubitemid 35013568)
224. Adinolfi, L.E., Gambardella, M., Andreana, A., Tripodi, M.F., Utili, R. & Ruggiero, G. (2001). Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33, 1358-1364. (Pubitemid 32496971)
225. Leandro, G., Mangia, A., Hui, J., Fabris, P., Rubbia-Brandt, L., Colloredo, G., Adinolfi, L.E., Asselah, T., Jonsson, J.R., Smedile, A., Terrault, N., Pazienza, V., Giordani, M.T., Giostra, E., Sonzogni, A., Ruggiero, G., Marcellin, P., Powell, E.E., George, J. & Negro, F. (2006). Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data. Gastroenterology 130, 1636-1642.
226. Monto, A., Alonzo, J., Watson, J.J., Grunfeld, C. & Wright, T.L. (2002). Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 36, 729-736. (Pubitemid 34977185)
227. Ratziu, V., Munteanu, M., Charlotte, F., Bonyhay, L. & Poynard, T. (2003). Fibrogenic impact of high serum glucose in chronic hepatitis C. Journal of Hepatology 39, 1049-1055. (Pubitemid 37523779)
228. Ortiz, V., Berenguer, M., Rayon, J.M., Carrasco, D. & Berenguer, J. (2002). Contribution of obesity to hepatitis C-related fibrosis progression. American Journal of Gastroenterology 97, 2408-2414.
229. Hourigan, L.F., Macdonald, G.A., Purdie, D., Whitehall, V.H., Shorthouse, C., Clouston, A. & Powell, E.E. (1999). Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29, 1215-1219. (Pubitemid 29168757)
230. Sulkowski, M.S. (2007). The HIV-coinfected patient: Managing viral hepatitis. Journal of Acquired Immune Deficiency Syndromes 45, Suppl. 2, S36-S37.
231. Soto, B., Sanchez-Quijano, A., Rodrigo, L., del Olmo, J.A., Garcia-Bengoechea, M., Hernandez-Quero, J., Rey, C., Abad, M.A., Rodriguez, M., Sales Gilabert, M., Gonzalez, F., Miron, P., Caruz, A., Relimpio, F., Torronteras, R., Leal, M. & Lissen, E. (1997). Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. Journal of Hepatology 26, 1-5. (Pubitemid 27072597)
232. Thomas, D.L., Shih, J.W., Alter, H.J., Vlahov, D., Cohn, S., Hoover, D.R., Cheung, L. & Nelson, K.E. (1996). Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. Journal of Infectious Diseases 174, 690-695. (Pubitemid 26325882)
233. Ragni, M.V. & Belle, S.H. (2001). Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. Journal of Infectious Diseases 183, 1112-1115. (Pubitemid 32230961)
234. Graham, C.S., Baden, L.R., Yu, E., Mrus, J.M., Carnie, J., Heeren, T. & Koziel, M.J. (2001). Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clinical Infectious Diseases 33, 562-569. (Pubitemid 32709592)
235. Gaeta, G.B., Stornaiuolo, G., Precone, D.F., Lobello, S., Chiaramonte, M., Stroffolini, T., Colucci, G. & Rizzetto, M. (2003). Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. Journal of Hepatology 39, 1036-1041. (Pubitemid 37523777)
236. Pontisso, P., Gerotto, M., Benvegnu, L., Chemello, L. & Alberti, A. (1998). Coinfection by hepatitis B virus and hepatitis C virus. Antiviral Therapy 3, 137-142. (Pubitemid 28528329)
237. Derbala, M.F., Al Kaabi, S.R., El Dweik, N.Z., Pasic, F., Butt, M.T., Yakoob, R., Al-Marri, A., Amer, A.M., Morad, N. & Bener, A. (2006). Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: Impact of bilharziasis and fibrosis stage. World Journal of Gastroenterology 12, 5692-5698. (Pubitemid 44594046)
238. Kamal, S., Madwar, M., Bianchi, L., Tawil, A.E., Fawzy, R., Peters, T. & Rasenack, J.W. (2000). Clinical, virological and histopathological features: Long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20, 281-289. (Pubitemid 30488534)
239. Bonkovsky, H.L., Banner, B.F. & Rothman, A.L. (1997). Iron and chronic viral hepatitis. Hepatology 25, 759-768. (Pubitemid 27106467)
240. Mori, M., Hara, M., Wada, I., Hara, T., Yamamoto, K., Honda, M. & Naramoto, J. (2000). Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. American Journal of Epidemiology 151, 131-139. (Pubitemid 30463643)
241. Pessione, F., Ramond, M.J., Njapoum, C., Duchatelle, V., Degott, C., Erlinger, S., Rueff, B., Valla, D.C. & Degos, F. (2001). Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34, 121-125. (Pubitemid 32591491)
242. Hutchinson, S.J., Bird, S.M. & Goldberg, D.J. (2005). Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clinical Gastroenterology & Hepatology 3, 1150-1159. (Pubitemid 41565383)
243. Harris, D.R., Gonin, R., Alter, H.J., Wright, E.C., Buskell, Z.J., Hollinger, F.B. & Seeff, L.B. (2001). The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Annals of Internal Medicine 134, 120-124. (Pubitemid 32096339)
244. Ostapowicz, G., Watson, K.J., Locarnini, S.A. & Desmond, P.V. (1998). Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 27, 1730-1735. (Pubitemid 28264702)
245. Layden-Almer, J.E., Ribeiro, R.M., Wiley, T., Perelson, A.S. & Layden, T.J. (2003). Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin. Hepatology 37, 1343-1350.
246. Asselah, T., Bieche, I., Laurendeau, I., Paradis, V., Vidaud, D., Degott, C., Martinot, M., Bedossa, P., Valla, D., Vidaud, M. & Marcellin, P. (2005). Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 129, 2064-2075. (Pubitemid 41772981)
247. Bieche, I., Asselah, T., Laurendeau, I., Vidaud, D., Degot, C., Paradis, V., Bedossa, P., Valla, D.C., Marcellin, P. & Vidaud, M. (2005). Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 332, 130-144. (Pubitemid 40127235)
248. Shao, R.X., Hoshida, Y., Otsuka, M., Kato, N., Tateishi, R., Teratani, T., Shiina, S., Taniguchi, H., Moriyama, M., Kawabe, T. & Omata, M. (2005). Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients. World Journal of Gastroenterology 11, 1995-1999. (Pubitemid 40520999)
249. Lau, D.T., Luxon, B.A., Xiao, S.Y., Beard, M.R. & Lemon, S.M. (2005). Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology 42, 273-281. (Pubitemid 41061079)
250. Smith, M.W., Walters, K.A., Korth, M.J., Fitzgibbon, M., Proll, S., Thompson, J.C., Yeh, M.M., Shuhart, M.C., Furlong, J.C., Cox, P.P., Thomas, D.L., Phillips, J.D., Kushner, J.P., Fausto, N., Carithers, R.L.J. & Katze, M.G. (2006). Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterology 130, 179-187. (Pubitemid 43049848)
251. Honda, M., Kaneko, S., Kawai, H., Shirota, Y. & Kobayashi, K. (2001). Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 120, 955-966. (Pubitemid 32193192)
252. Pelkmans, L., Fava, E., Grabner, H., Hannus, M., Habermann, B., Krausz, E. & Zerial, M. (2005). Genome-wide analysis of human kinases in clathrin-and caveolae/raft-mediated endocytosis. Nature, London 436, 78-86. (Pubitemid 40966188)
253. Carpenter, A.E. & Sabatini, D.M. (2004). Syst ematic genome-wide screens of gene function. Nature Reviews Genetics 5, 11-22. (Pubitemid 38055332)
254. Erfle, H., Simpson, J.C., Bastiaens, P.I. & Pepperkok, R. (2004). siRNA cell arrays for high-content screening microscopy. BioTechniques 37, 454-458, 460, 462.
255. Matula, P., Kumar, A., Wörz, I., Erfle, H., Bartenschlager, R., Eils, R. & Rohr, K. (2009). Single-cellbased image analysis of high-throughput cell array screens for quantification of viral infection. Cytometry A 75, 309-318.
256. Pfeffer, S. & Baumert, T.F. (2009). Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver. Journal of Hepatology 51, 606-609.
257. Vaillancourt, F.H., Pilote, L., Cartier, M., Lippens, J., Liuzzi, M., Bethell, R.C., Cordingley, M.G. & Kukolj, G. (2009). Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology 387, 5-10.
258. Ahn, J., Chung, K.S., Kim, D.U., Won, M., Kim, L., Kim, K.S., Nam, M., Choi, S.J., Kim, H.C., Yoon, M., Chae, S.K. & Hoe, K.L. (2004). Systematic identification of hepatocellular proteins interacting with NS5A of the hepatitis C virus. Journal of Biochemistry & Molecular Biology 37, 741-748. (Pubitemid 40221537)
259. Mannova, P., Fang, R., Wang, H., Deng, B., McIntosh, M.W., Hanash, S.M. & Beretta, L. (2006). Modification of host lipid raft proteome upon hepatitis C virus replication. Molecular & Cellular Proteomics 5, 2319-2325. (Pubitemid 46040636)
260. Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B.K. & Ganz, T. (2004). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation 113, 1271-1276. (Pubitemid 39069926)
261. Aoki, C.A., Rossaro, L., Ramsamooj, R., Brandhagen, D., Burritt, M.F. & Bowlus, C.L. (2005). Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. Journal of Clinical Gastroenterology 39, 71-74. (Pubitemid 40041349)
262. Calvisi, D.F., Ladu, S., Gorden, A., Farina, M., Lee, J.S., Conner, E.A., Schroeder, I., Factor, V.M. & Thorgeirsson, S.S. (2007). Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. Journal of Clinical Investigation 117, 2713-2722.
263. Li, X., Hui, A.M., Sun, L., Hasegawa, K., Torzilli, G., Minagawa, M., Takayama, T. & Makuuchi, M. (2004). p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clinical Cancer Research 10, 7484-7489. (Pubitemid 39557509)
264. Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H. & Yoshimura, A. (2004). SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. Journal of Experimental Medicine 199, 1701-1707. (Pubitemid 38822003)
265. Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T. & Yoshimura, A. (2006). Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 25, 2520-2530.
266. Di Gioia, S., Bianchi, P., Destro, A., Grizzi, F., Malesci, A., Laghi, L., Levrero, M., Morabito, A. & Roncalli, M. (2006). Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. BMC Cancer 6, 89.
267. Nishida, N., Nagasaka, T., Nishimura, T., Ikai, I., Boland, C.R. & Goel, A. (2008). Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 47, 908-918. (Pubitemid 351449682)
268. Ura, S., Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., Sunakozaka, H., Sakai, Y., Horimoto, K. & Kaneko, S. (2009). Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49, 1098-1112.
269. Yano, M., Ikeda, M., Abe, K.I., Kawai, Y., Kuroki, M., Mori, K., Dansako, H., Ariumi, Y., Ohkoshi, S., Aoyagi, Y. & Kato, N. (2009). Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase. Hepatology 50, 678-688.
270. Choi, J., Forman, H.J., Ou, J.H., Lai, M.M., Seronello, S. & Nandipati, A. (2006). Redox modulation of the hepatitis C virus replication complex is calcium dependent. Free Radical Biology & Medicine 41, 1488-1498. (Pubitemid 44466731)
271. Waris, G. & Siddiqui, A. (2005). Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: Role of prostaglandin E2 in RNA replication. Journal of Virology 79, 9725-9734. (Pubitemid 41022315)
272. Choi, J., Lee, K.J., Zheng, Y., Yamaga, A.K., Lai, M.M. & Ou, J.H. (2004). Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39, 81-89. (Pubitemid 38461470)
273. Trujillo-Murillo, K., Rincon-Sanchez, A.R., Martinez-Rodriguez, H., Bosques-Padilla, F., Ramos-Jimenez, J., Barrera-Saldana, H.A., Rojkind, M. & Rivas-Estilla, A.M. (2008). Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways. Hepatology 47, 1462-1472. (Pubitemid 351702730)
274. Huang, Y., Chen, X.C., Konduri, M., Fomina, N., Lu, J., Jin, L., Kolykhalov, A. & Tan, S.L. (2006). Mechanistic link between the anti-HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade. Hepatology 43, 81-90. (Pubitemid 43733594)
275. Takeshita, M., Ishida, Y.I., Akamatsu, E., Ohmori, Y., Sudoh, M., Uto, H., Tsubouchi, H. & Kataoka, H. (2009). Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA. Journal of Biological Chemistry 284, 21,165-21,176.
276. Ujino, S., Yamaguchi, S., Shimotohno, K. & Takaku, H. (2009). Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3. Journal of Biological Chemistry 284, 6841-6846.
277. Wagner, R., Larson, D.P., Beno, D.W., Bosse, T.D., Darbyshire, J.F., Gao, Y., Gates, B.D., He, W., Henry, R.F., Hernandez, L.E., Hutchinson, D.K., Jiang, W.W., Kati, W.M., Klein, L.L., Koev, G., Kohlbrenner, W., Krueger, A.C., Liu, J., Liu, Y., Long, M.A., Maring, C.J., Masse, S.V., Middleton, T., Montgomery, D.A., Pratt, J.K., Stuart, P., Molla, A. & Kempf, D.J. (2009). Inhibitors of hepatitis C virus polymerase: Synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl- benzothiadiazines. Journal of Medicinal Chemistry 52, 1659-1669.
278. Wang, S.Y., Tseng, C.P., Tsai, K.C., Lin, C.F., Wen, C.Y., Tsay, H.S., Sakamoto, N., Tseng, C.H. & Cheng, J.C. (2009). Bioactivity-guided screening identifies pheophytin a as a potent anti-hepatitis C virus compound from Lonicera hypoglauca Miq. Biochemical & Biophysical Research Communications 385, 230-235.
279. Ikeda, M., Mori, K., Ariumi, Y., Dansako, H. & Kato, N. (2009). Oncostatin M synergistically inhib its HCV RNA replication in combination with interferon-alpha. FEBS Letters 583, 1434-1438.
280. Zhang, Y.L., Guo, Y.J., Bin, L. & Sun, S.H. (2009). Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7. Journal of Hepatology 51, 29-38.
281. Liu, Z., Yang, F., Robotham, J.M. & Tang, H. (2009). Critical role of cyclophilin A and its prolylpeptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex. Journal of Virology 83, 6554-6565.
282. Liu, H.M., Aizaki, H., Choi, K.S., Machida, K., Ou, J.J. & Lai, M.M. (2009). SYNCRIP (synaptotagmin- binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication. Virology 386, 249-256.
283. Locarnini, S.A. & Bartholomeusz, A. (2002). Advances in hepatitis C: What is coming in the next 5 years? Journal of Gastroenterology & Hepatology 17, 442-447.
284. Chen, Y.R., Chen, T.Y., Zhang, S.L., Lin, S.M., Zhao, Y.R., Ye, F., Zhang, X., Shi, L., Dang, S.S. & Liu, M. (2009). Identification of a novel protein binding to hepatitis C virus core protein. Journal of Gastroenterology & Hepatology 24, 1300-1304.
285. Gondeau, C., Pichard-Garcia, L. & Maurel, P. (2009). Cellular models for the screening and development of anti-hepatitis C virus agents. Pharmacology & Therapeutics 124, 1-22.
286. Heck, J.A., Meng, X. & Frick, D.N. (2009). Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase. Biochemical Pharmacology 77, 1173-1180.
287. Paeshuyse, J., Kaul, A., De Clercq, E., Rosenwirth, B., Dumont, J.M., Scalfaro, P., Bartenschlager, R. & Neyts, J. (2006). The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology 43, 761-770.
288. Watashi, K., Hijikata, M., Hosaka, M., Yamaji, M. & Shimotohno, K. (2003). Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 38, 1282-1288. (Pubitemid 37314838)
289. Nakagawa, M., Sakamoto, N., Enomoto, N., Tanabe, Y., Kanazawa, N., Koyama, T., Kurosaki, M., Maekawa, S., Yamashiro, T., Chen, C.H., Itsui, Y., Kakinuma, S. & Watanabe, M. (2004). Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochemical & Biophysical Research Communications 313, 42-47. (Pubitemid 37524022)
290. Goodchild, A., Nopper, N., Craddock, A., Law, T., King, A., Fanning, G., Rivory, L. & Passioura, T. (2009). Primary leukocyte screens for innate immune agonists. Journal of Biomolecular Screening 14, 723-730.
291. Mondal, R., Koev, G., Pilot-Matias, T., He, Y., Ng, T., Kati, W. & Molla, A. (2009). Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well. Antiviral Research 82, 82-88.
292. Ziegler, S., Kronenberger, B., Albrecht, B.A., Kaul, A., Gamer, A.L., Klein, C.D. & Hartmann, R.W. (2009). Development and evaluation of a FACSbased medium-throughput assay for HCV entry inhibitors. Journal of Biomolecular Screening 14, 620-626.
293. Aly, H.H., Qi, Y., Atsuzawa, K., Usuda, N., Takada, Y., Mizokami, M., Shimotohno, K. & Hijikata, M. (2009). Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus. Hepatology 50, 689-696.
294. Iro, M., Witteveldt, J., Angus, A.G., Woerz, I., Kaul, A., Bartenschlager, R. & Patel, A.H. (2009). A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication. Antiviral Research 83, 148-155.
295. Tai, A.W., Benita, Y., Peng, L.F., Kim, S.S., Sakamoto, N., Xavier, R.J. & Chung, R.T. (2009). A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host & Microbe 5, 298-307.
296. Ng, T.I., Mo, H., Pilot-Matias, T., He, Y., Koev, G., Krishnan, P., Mondal, R., Pithawalla, R., He, W., Dekhtyar, T., Packer, J., Schurdak, M. & Molla, A. (2007). Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology 45, 1413-1421. (Pubitemid 46918325)
297. Randall, G., Panis, M., Cooper, J.D., Tellinghuisen, T.L., Sukhodolets, K.E., Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S., Lindenbach, B.D., Chien, M., Weir, D.B., Russo, J.J., Ju, J., Brownstein, M.J., Sheridan, R., Sander, C., Zavolan, M., Tuschl, T. & Rice, C.M. (2007). Cellular cofactors affecting hepatitis C virus infection and replication. Proceedings of the National Academy of Sciences of the USA 104, 12,884-12,889.
298. Supekova, L., Supek, F., Lee, J., Chen, S., Gray, N., Pezacki, J.P., Schlapbach, A. & Schultz, P.G. (2008). Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. Journal of Biological Chemistry 283, 29-36.
299. Fornari, F., Gramantieri, L., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G.A., Grazi, G.L., Giovannini, C., Croce, C.M., Bolondi, L. & Negrini, M. (2008). MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27, 5651-5661.
300. Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C.G., Calin, G.A., Giovannini, C., Ferrazzi, E., Grazi, G.L., Croce, C.M., Bolondi, L. & Negrini, M. (2007). Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Research 67, 6092-6099. (Pubitemid 47037488)
301. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S.T. & Patel, T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658. (Pubitemid 47187346)
302. Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T. & Shimotohno, K. (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and nontumorous tissues. Oncogene 25, 2537-2545.
303. Jiang, J., Gusev, Y., Aderca, I., Mettler, T.A., Nagorney, D.M., Brackett, D.J., Roberts, L.R. & Schmittgen, T.D. (2008). Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clinical Cancer Research 14, 419-427. (Pubitemid 351226109)
304. Mehta, P., Ploutz-Snyder, R., Nandi, J., Rawlins, S.R., Sanderson, S.O. & Levine, R.A. (2008). Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C. American Journal of Gastroenterology 103, 928-936. (Pubitemid 351501097)
305. Huang, Y., Yang, H., Borg, B.B., Su, X., Rhodes, S.L., Yang, K., Tong, X., Tang, G., Howell, C.D., Rosen, H.R., Thio, C.L., Thomas, D.L., Alter, H.J., Sapp, R.K. & Liang, T.J. (2007). A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proceedings of the National Academy of Sciences of the USA 104, 985-990. (Pubitemid 46154723)
306. Morgan, T.R., Lambrecht, R.W., Bonkovsky, H.L., Chung, R.T., Naishadham, D., Sterling, R.K., Fontana, R.J., Lee, W.M., Ghany, M.G., Wright, E.C. & O'Brien, T.R. (2008). DNA polymorphisms and response to treatment in patients with chronic hepatitis C: Results from the HALT-C trial. Journal of Hepatology 49, 548-556.
307. Chen, L., Borozan, I., Feld, J., Sun, J., Tannis, L.L., Coltescu, C., Heathcote, J., Edwards, A.M. & McGilvray, I.D. (2005). Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128, 1437-1444. (Pubitemid 40712193)
308. Feld, J.J., Nanda, S., Huang, Y., Chen, W., Cam, M., Pusek, S.N., Schweigler, L.M., Theodore, D., Zacks, S.L., Liang, T.J. & Fried, M.W. (2007). Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. Hepatology 46, 1548-1563. (Pubitemid 350155537)
309. Hayashida, K., Daiba, A., Sakai, A., Tanaka, T., Kaji, K., Inaba, N., Ando, S., Kajiyama, N., Terasaki, H., Abe, A., Ogasawara, M., Kohara, M., Harada, M., Okanoue, T., Ito, S. & Kaneko, S. (2005). Pretreatment prediction of interferon-alfa efficacy in chronic hepatitis C patients. Clinical Gastroenterology & Hepatology 3, 1253-1259. (Pubitemid 41797678)
310. Persico, M., Capasso, M., Russo, R., Persico, E., Croce, L., Tiribelli, C. & Iolascon, A. (2008). Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut 57, 507-515. (Pubitemid 351442535)
311. Aborsangaya, K.B., Dembinski, I., Khatkar, S., Alphonse, M.P., Nickerson, P. & Rempel, J.D. (2007). Impact of aboriginal ethnicity on HCV coreinduced IL-10 synthesis: Interaction with IL-10 gene polymorphisms. Hepatology 45, 623-630.
312. Larcombe, L., Rempel, J.D., Dembinski, I., Tinckam, K., Rigatto, C. & Nickerson, P. (2005). Differential cytokine genotype frequencies among Canadian Aboriginal and Caucasian populations. Genes & Immunity 6, 140-144. (Pubitemid 40439540)
313. Rempel, J.D., Aborsangaya, K.B., Alphonse, M.P. & Minuk, G.Y. (2009). The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha. Journal of Viral Hepatitis 16, 292-297.
314. Kawai, Y., Ikeda, M., Abe, K.I., Yano, M., Ariumi, Y., Dansako, H., Yamamoto, K. & Kato, N. (2009). Development of a hepatitis C virus relapse model using genome-length hepatitis C virus ribonucleic acid-harboring cells possessing the interferon-alpha-resistance phenotype. Hepatology Research 39, 898-909.
315. Byers, A.M., Tapia, T.M., Sassano, E.R. & Wittman, V. (2009). In vitro antibody response to tetanus in the MIMIC system is a representative measure of vaccine immunogenicity. Biologicals 37, 148-151.
316. Shudo, E., Ribeiro, R.M. & Perelson, A.S. (2009). Modeling HCV kinetics under therapy using PK and PD information. Expert Opinion on Drug Metabolism & Toxicology 5, 321-332.
317. Neumann, A.U., Lam, N.P., Dahari, H., Gretch, D.R., Wiley, T.E., Layden, T.J. & Perelson, A.S. (1998). Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science, New York 282, 103-107.
318. Perelson, A.S. & Ribeiro, R.M. (2008). Estimating drug efficacy and viral dynamic parameters: HIV and HCV. Statistics in Medicine 27, 4647-4657.
319. Perelson, A.S., Herrmann, E., Micol, F. & Zeuzem, S. (2005). New kinetic models for the hepatitis C virus. Hepatology 42, 749-754. (Pubitemid 41401110)
320. Herrmann, E. & Zeuzem, S. (2006). The kinetics of hepatitis C virus. European Journal of Gastroenterology & Hepatology 18, 339-342.
321. Dixit, N.M. & Perelson, A.S. (2006). The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus. Cellular & Molecular Life Sciences 63, 832-842. (Pubitemid 43724073)